OXALIPLATIN
Drug timelines are a Plus or Pro feature.
810 regulatory and trial events tracked for OXALIPLATIN, covering 2006-07-11 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Results: Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [Phase 2]